Premium
P4‐291: Assessing the Impact of a Centralized Data Review on the Reliability of the Alzheimer’S Disease Assessment Scale‐Cognitive (ADAS‐COG)
Author(s) -
Khan Anzalee,
Atkins Alexandra S.,
Stroescu Ioan,
Davis Vicki,
Williamson Tiffany,
Mozley Lyn Harper,
Voss Tiffini,
McMahon Kerry Budd,
Keefe Richard SE.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - Czech
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.07.033
Subject(s) - neurocognitive , reliability (semiconductor) , cronbach's alpha , medicine , placebo , clinical trial , cognition , psychology , psychometrics , clinical psychology , psychiatry , pathology , power (physics) , physics , alternative medicine , quantum mechanics
Anzalee Khan, Alexandra S. Atkins, Ioan Stroescu, Vicki Davis, Tiffany Williamson, Lyn Harper Mozley, Tiffini Voss, Kerry Budd McMahon, Richard SE. Keefe, Neurocog Trials, Durham, NC, USA; 2 Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA; 3 NeuroCog Trials, Durham, NC, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, NJ, USA; Duke University Medical Center, Durham, NC, USA. Contact e-mail: anzalee.khan@ neurocogtrials.com